Sana Biotechnology SANA Stock
Sana Biotechnology Price Chart
Sana Biotechnology SANA Financial and Trading Overview
| Sana Biotechnology stock price | 4.41 USD |
| Previous Close | 6.3 USD |
| Open | 6.24 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 900 |
| Day's Range | 6.14 - 6.57 USD |
| 52 Week Range | 2.99 - 9.55 USD |
| Volume | 1.06M USD |
| Avg. Volume | 1.39M USD |
| Market Cap | 1.24B USD |
| Beta (5Y Monthly) | 0.706212 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.96 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10 USD |
SANA Valuation Measures
| Enterprise Value | 971.62M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.3624163 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.9056773 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -3.223 |
Trading Information
Sana Biotechnology Stock Price History
| Beta (5Y Monthly) | 0.706212 |
| 52-Week Change | 26.21% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 9.55 USD |
| 52 Week Low | 2.99 USD |
| 50-Day Moving Average | 5.82 USD |
| 200-Day Moving Average | 5.01 USD |
SANA Share Statistics
| Avg. Volume (3 month) | 1.39M USD |
| Avg. Daily Volume (10-Days) | 1.21M USD |
| Shares Outstanding | 191.5M |
| Float | 93.43M |
| Short Ratio | 17.88 |
| % Held by Insiders | 11.21% |
| % Held by Institutions | 91.08% |
| Shares Short | 28.28M |
| Short % of Float | 30.64% |
| Short % of Shares Outstanding | 14.77% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -22.13% |
| Return on Equity (ttm) | -56.66% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -301449984 USD |
| Net Income Avi to Common (ttm) | -320151008 USD |
| Diluted EPS (ttm) | -1.66 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 349.31M USD |
| Total Cash Per Share (mrq) | 1.82 USD |
| Total Debt (mrq) | 114.5M USD |
| Total Debt/Equity (mrq) | 26.74 USD |
| Current Ratio (mrq) | 3.599 |
| Book Value Per Share (mrq) | 2.237 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -291612992 USD |
| Levered Free Cash Flow (ttm) | -162208368 USD |
Profile of Sana Biotechnology
| Country | United States |
| State | WA |
| City | Seattle |
| Address | 188 East Blaine Street |
| ZIP | 98102 |
| Phone | 206 701 7914 |
| Website | https://www.sana.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 424 |
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG299 and SG242 that targets CD19+ cancer cells in patients with non-Hodgkin Lymphoma (NHL), chronic lymphocytic leukemia (CLL), and acute lymphoblastic leukemia (ALL); SG221 and SG239 for the treatment of multiple myeloma; and SG233, a CD22 CAR for the treatment of NHL, CLL, and ALL. It also develops SG418 for sickle cell disease and beta-thalassemia; SC291, a CD19 allogeneic T cell therapy; SC255, a B cell maturation antigen directed allogeneic CAR T for multiple myeloma; SC45, the PSC-derived pancreatic islet cells for type I diabetes mellitus; and SC379 for secondary progressive multiple sclerosis, Pelizaeus-Merzbacher disease, Huntington's disease, and other astrocytic diseases. The company was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. The company was incorporated in 2018 and is based in Seattle, Washington.
Q&A For Sana Biotechnology Stock
What is a current SANA stock price?
Sana Biotechnology SANA stock price today per share is 4.41 USD.
How to purchase Sana Biotechnology stock?
You can buy SANA shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sana Biotechnology?
The stock symbol or ticker of Sana Biotechnology is SANA.
Which industry does the Sana Biotechnology company belong to?
The Sana Biotechnology industry is Biotechnology.
How many shares does Sana Biotechnology have in circulation?
The max supply of Sana Biotechnology shares is 266.37M.
What is Sana Biotechnology Price to Earnings Ratio (PE Ratio)?
Sana Biotechnology PE Ratio is now.
What was Sana Biotechnology earnings per share over the trailing 12 months (TTM)?
Sana Biotechnology EPS is -0.96 USD over the trailing 12 months.
Which sector does the Sana Biotechnology company belong to?
The Sana Biotechnology sector is Healthcare.
Sana Biotechnology SANA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 23593.1 USD — |
-0.09
|
4.43B USD — | 23567.86 USD — | 23665.15 USD — | — - | 4.43B USD — |
| US Tech US 700 Small Cap Index NQUS700SC | 2666.44 USD — |
-0.42
|
— — | 2657.64 USD — | 2673.31 USD — | — - | — — |
| Stlmt ID US Tech Biotechnology NBX | 3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| US Tech Global Select Market Com NQGS | 11560.74 USD — |
-0.05
|
— — | 11548.2 USD — | 11595.66 USD — | — - | — — |
| US Tech Biotechnology NBI | 5809.25 USD — |
-0.59
|
— — | 5792.54 USD — | 5835.34 USD — | — - | — — |
| US Tech Health Care IXHC | 1206.13 USD — |
-0.49
|
— — | 1203.49 USD — | 1210.54 USD — | — - | — — |
- {{ link.label }} {{link}}